Nucleocytoplasmic Interactions and Dynamics in Emery-Dreifuss Muscular Dystrophy

埃默里-德莱福斯肌营养不良症的核细胞质相互作用和动力学

基本信息

  • 批准号:
    8869806
  • 负责人:
  • 金额:
    $ 52.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Emery-Dreifuss muscular dystrophy (EDMD) is caused by mutations in genes encoding proteins of the nuclear envelope. Autosomal EDMD results from mutations in LMNA, which encodes A-type lamins, and X-linked EDMD from mutations in EMD, which encodes emerin. Mutations in genes encoding nesprins and SUNs have also been associated with the EDMD phenotype. The proteins encoded by these genes are involved in connecting the inside of the nucleus to the cytoplasm, forming or associating with the LINC complex. We have shown that LMNA mutations causing autosomal EDMD, as well as deficiency of A-type lamins, block cytoplasmic actin-dependent nuclear movement by disrupting anchoring of the nucleus to structures known as TAN lines, which are composed of SUN2 and nesprin-2. Loss of emerin, as occurs in X-linked EDMD, additionally blocks nuclear movement by altering retrograde cytoplasmic actin flow that drives it. Depletion of SUNs and nesprins also leads to defective nuclear movement by altering TAN line function. In cells lacking A- type lamins, inhibition of ERK1/2, which is activated by alterations in lamins, emerin, SUNs and nesprins as well as in striated muscle of animal models of autosomal EDMD, reverses the nuclear movement defect. We now propose to test the hypothesis that there is a link between genetic alterations that cause EDMD and the nuclear movement defects and ERK1/2 activation they create. To test this hypothesis, we will utilize an innovative fibroblast-based assay to mechanistically dissect defects in nuclear movement and then extend the findings to cultured myoblasts and skeletal muscle in vivo. In Aim 1, we will examine the relationship between LINC complex function, ERK1/2 activity and nuclear movement, with a focus on how hyperactivated ERK1/2 prevents nuclear movement. In Aim 2, we will examine the temporal relationship between nuclear movement and ERK1/2 activity during physiological activation of the kinase and perform a series of biophysical experiments to directly test if moving the nucleus regulates ERK1/2 signaling. In Aims 3 and 4, we will extend our studies into muscle cells, examining how LINC complex proteins and ERK1/2 affect nuclear movement in migrating myoblasts and determining if A-type lamins and emerin affect proper nuclear positioning in muscle, in mouse models of EDMD with alterations in lamins or emerin. Overall, this research will provide novel insights into the cellular pathology of EDMD and simultaneously uncover new information about nuclear movement, a cellular function of broad significance to basic cell biology.
描述(由申请人提供):Emery-Dreifuss肌营养不良症(EDMD)是由编码核膜蛋白的基因突变引起的。常染色体EDMD由编码A型核纤层蛋白的LMNA突变引起,X连锁EDMD由编码Emerin的EMD突变引起。编码nesprins和SUN的基因突变也与EDMD表型相关。由这些基因编码的蛋白质参与连接细胞核内部与细胞质,形成或与LINC复合体结合。我们已经表明,LMNA突变导致常染色体EDMD,以及A型核纤层蛋白的缺乏,通过破坏细胞核与称为TAN系的结构的锚定来阻断细胞质肌动蛋白依赖性核运动,TAN系由SUN 2和nesprin-2组成。Emerin的缺失,如发生在X连锁EDMD中,通过改变驱动细胞核运动的逆行细胞质肌动蛋白流而另外阻断细胞核运动。在缺乏A型核纤层蛋白的细胞中,ERK 1/2的抑制可逆转核运动缺陷,ERK 1/2是由核纤层蛋白、Emerin、SUN和nesprin以及常染色体EDMD动物模型的横纹肌中的改变激活的.我们现在建议测试的假设,有一个基因改变,导致EDMD和核运动缺陷和ERK 1/2激活它们创建之间的联系。为了验证这一假设,我们将利用一种创新的基于成纤维细胞的检测方法来机械地解剖核运动中的缺陷,然后将研究结果扩展到体内培养的成肌细胞和骨骼肌。在目的1中,我们将研究LINC复合体功能,ERK 1/2活性和核运动之间的关系,重点是过度激活的ERK 1/2如何阻止核运动。在目标2中,我们将研究在激酶的生理激活过程中细胞核运动和ERK 1/2活性之间的时间关系,并进行一系列生物物理实验,以直接测试细胞核运动是否调节ERK 1/2信号传导。在目标3和4中,我们将把我们的研究扩展到肌肉细胞,研究LINC复合物蛋白和ERK 1/2如何影响迁移成肌细胞的核运动,并确定A型核纤层蛋白和emerin是否影响肌肉中适当的核定位,在EDMD小鼠模型中改变核纤层蛋白或emerin。总的来说,这项研究将为EDMD的细胞病理学提供新的见解,同时揭示有关核运动的新信息,这是一种对基础细胞生物学具有广泛意义的细胞功能。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregg G Gundersen其他文献

Gregg G Gundersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregg G Gundersen', 18)}}的其他基金

Mechanistic Basis of Cardiac Laminopathy
心脏核纤层病的机制基础
  • 批准号:
    10650433
  • 财政年份:
    2021
  • 资助金额:
    $ 52.17万
  • 项目类别:
Mechanistic Basis of Cardiac Laminopathy
心脏核纤层病的机制基础
  • 批准号:
    10279393
  • 财政年份:
    2021
  • 资助金额:
    $ 52.17万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10396505
  • 财政年份:
    2020
  • 资助金额:
    $ 52.17万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10613943
  • 财政年份:
    2020
  • 资助金额:
    $ 52.17万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10799051
  • 财政年份:
    2020
  • 资助金额:
    $ 52.17万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10289402
  • 财政年份:
    2019
  • 资助金额:
    $ 52.17万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    9982166
  • 财政年份:
    2019
  • 资助金额:
    $ 52.17万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10153650
  • 财政年份:
    2019
  • 资助金额:
    $ 52.17万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10394870
  • 财政年份:
    2019
  • 资助金额:
    $ 52.17万
  • 项目类别:
Integrin Recycling and Adhesion Formation in Cell Migration
细胞迁移中整合素的回收和粘附形成
  • 批准号:
    9765849
  • 财政年份:
    2019
  • 资助金额:
    $ 52.17万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 52.17万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了